Eli Lilly & Co. vs Stryker Corporation
LLY vs SYK — side-by-side comparison from reported financials. LLY leads 7, SYK leads 4 of 11 comparable metrics.
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
Stryker Corporation
SYK · Healthcare
$277.70+0.26%Mixed
| Metric | LLY | SYK |
|---|---|---|
| Price | $1 177.20 | $277.70 |
| Market cap | $1.05T | $107B |
| Revenue (TTM) | $79.7B | $25.8B |
| Revenue growth | +31.7% | +10.8% |
| Net margin | 33.5% | 14.4% |
| Free cash flow | $18.2B | $4.70B |
| Net cash (debt) | ($35.2B) | ($11.8B) |
| 1-year price return | +37.6% | -25.0% |
| P/E | 41.6 | 28.5 |
| P/E vs own history (cheap-side %) | 88% | 99% |
| Dividend yield | 0.52% | 1.24% |
| Return on equity | 93% | 16% |
| Altman Z-score | 7.10 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 50,000 | 56,000 |
Full résumé-style profiles: LLY CV · SYK CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.